Drug discovery
inspired by viruses

Over millions of years of evolution, viruses have perfected their ability to modulate and hijack the cell functions for their own benefit.

ENYO Pharma’s founders have deciphered virus-host interactions and built a unique concept based on mimetism of the virus strategy for modulation of cellular functions. Thanks to a discovery engine, they are developing innovative drug discovery programs on many intracellular host targets yet untapped by pharma’s.

ENYO Pharma is currently focusing on hepatic diseases with two leading programs – chronic hepatitis B and NASH. Host-oriented ENYO Pharma’s drugs are also opening perspectives for a wide range of other therapeutic areas such as oncology.